GlassScriptPhysician profile
Harris S Goodman
NPI 1366553687
$2,582.40
in general payments reported to CMS, 2019-2025
10 companies · $1,010 in 2025
The $1,010 reported for 2025 was more than what 88% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2021: $124 · 2022: $281 · 2023: $21.14 · 2024: $37.89 · 2025: $1,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574 · Travel and Lodging: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.32 |
| Travel and Lodging | $494.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beckman Coulter, INC. | $863.36 | 2019-2025 | Dxu Iris, Dxh 900 Hematology System |
| Astrazeneca Pharmaceuticals LP | $558.65 | 2019-2024 | |
| Abbott Laboratories | $332.81 | 2019 | |
| Alexion Pharmaceuticals, INC. | $250.05 | 2021-2022 | |
| Exelixis INC. | $135.00 | 2019 | |
| Pharmacosmos Therapeutics INC. | $129.27 | 2025 | Monoferric |
| Astellas Pharma US INC | $125.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $87.94 | 2019 | |
| Hologic Sales and Service, LLC | $80.63 | 2022-2025 | Aptima, Panther Fusion, Affirm Prone Biopsy System |
| Tempus Ai, INC | $19.69 | 2025 | Xt Cdx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harris Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.